| Product Code: ETC7647618 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Cell And Gene Therapy Manufacturing Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Cell And Gene Therapy Manufacturing Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Cell And Gene Therapy Manufacturing Market - Industry Life Cycle |
3.4 Israel Cell And Gene Therapy Manufacturing Market - Porter's Five Forces |
3.5 Israel Cell And Gene Therapy Manufacturing Market Revenues & Volume Share, By Therapy Type, 2021 & 2031F |
3.6 Israel Cell And Gene Therapy Manufacturing Market Revenues & Volume Share, By Scale, 2021 & 2031F |
3.7 Israel Cell And Gene Therapy Manufacturing Market Revenues & Volume Share, By Mode, 2021 & 2031F |
3.8 Israel Cell And Gene Therapy Manufacturing Market Revenues & Volume Share, By Workflow, 2021 & 2031F |
4 Israel Cell And Gene Therapy Manufacturing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Growing demand for personalized medicines and targeted therapies |
4.2.2 Technological advancements in cell and gene therapy manufacturing processes |
4.2.3 Increasing investments in research and development in the field of cell and gene therapy |
4.3 Market Restraints |
4.3.1 High costs associated with cell and gene therapy manufacturing |
4.3.2 Stringent regulatory requirements and compliance standards |
4.3.3 Limited skilled workforce and expertise in cell and gene therapy manufacturing |
5 Israel Cell And Gene Therapy Manufacturing Market Trends |
6 Israel Cell And Gene Therapy Manufacturing Market, By Types |
6.1 Israel Cell And Gene Therapy Manufacturing Market, By Therapy Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Therapy Type, 2021- 2031F |
6.1.3 Israel Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Cell therapy manufacturing, 2021- 2031F |
6.1.4 Israel Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Gene therapy manufacturing, 2021- 2031F |
6.2 Israel Cell And Gene Therapy Manufacturing Market, By Scale |
6.2.1 Overview and Analysis |
6.2.2 Israel Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Pre-commercial/R&D scale manufacturing, 2021- 2031F |
6.2.3 Israel Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Commercial scale manufacturing, 2021- 2031F |
6.3 Israel Cell And Gene Therapy Manufacturing Market, By Mode |
6.3.1 Overview and Analysis |
6.3.2 Israel Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Contract manufacturing, 2021- 2031F |
6.3.3 Israel Cell And Gene Therapy Manufacturing Market Revenues & Volume, By In-house manufacturing, 2021- 2031F |
6.4 Israel Cell And Gene Therapy Manufacturing Market, By Workflow |
6.4.1 Overview and Analysis |
6.4.2 Israel Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Cell processing, 2021- 2031F |
6.4.3 Israel Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Cell banking, 2021- 2031F |
6.4.4 Israel Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Process development, 2021- 2031F |
6.4.5 Israel Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Fill & finish operations, 2021- 2031F |
6.4.6 Israel Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Analytical and quality testing, 2021- 2031F |
6.4.7 Israel Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Raw material testing, 2021- 2031F |
6.4.8 Israel Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Others, 2021- 2031F |
6.4.9 Israel Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Others, 2021- 2031F |
7 Israel Cell And Gene Therapy Manufacturing Market Import-Export Trade Statistics |
7.1 Israel Cell And Gene Therapy Manufacturing Market Export to Major Countries |
7.2 Israel Cell And Gene Therapy Manufacturing Market Imports from Major Countries |
8 Israel Cell And Gene Therapy Manufacturing Market Key Performance Indicators |
8.1 Number of successful clinical trials conducted in Israel for cell and gene therapies |
8.2 Investment in infrastructure and facilities for cell and gene therapy manufacturing in Israel |
8.3 Number of patents filed for innovative cell and gene therapy manufacturing technologies in Israel |
9 Israel Cell And Gene Therapy Manufacturing Market - Opportunity Assessment |
9.1 Israel Cell And Gene Therapy Manufacturing Market Opportunity Assessment, By Therapy Type, 2021 & 2031F |
9.2 Israel Cell And Gene Therapy Manufacturing Market Opportunity Assessment, By Scale, 2021 & 2031F |
9.3 Israel Cell And Gene Therapy Manufacturing Market Opportunity Assessment, By Mode, 2021 & 2031F |
9.4 Israel Cell And Gene Therapy Manufacturing Market Opportunity Assessment, By Workflow, 2021 & 2031F |
10 Israel Cell And Gene Therapy Manufacturing Market - Competitive Landscape |
10.1 Israel Cell And Gene Therapy Manufacturing Market Revenue Share, By Companies, 2024 |
10.2 Israel Cell And Gene Therapy Manufacturing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here